House of Lords portcullis
House of Lords
Session 2013 - 14
Internet Publications
Other Bills before Parliament

Finance Bill


Finance Bill
Schedule 15 — R&D expenditure credits
Part 1 — Amendments of CTA 2009

257

 

104O    

Amounts deducted by way of tax adjustment

(1)   

This section applies if—

(a)   

a company is entitled to an R&D expenditure credit for an

accounting period under this Chapter, and

(b)   

the amount of the set-off amount remaining after step 1 in

5

section 104N(2) is greater than the net value of the set-off

amount.

(2)   

An amount equal to the difference between—

(a)   

the amount remaining after step 1 in section 104N(2), and

(b)   

the net value of the set-off amount,

10

   

(“the step 2 amount”) is to be applied in discharging any liability of

the company to pay corporation tax for any subsequent accounting

period.

   

This is subject to subsection (3).

(3)   

If the company is a member of a group, it may surrender the whole

15

or any part of the step 2 amount to any other member of the group

(the “relevant group member”).

   

In such a case, section 104R(3) applies to the amount surrendered as

it applies to an amount of R&D expenditure credit surrendered

under step 5 in section 104N(2).

20

(4)   

If any of the amount surrendered under subsection (3) is remaining

after the operation of step 3 in section 104R(3), it is to be treated for

the purposes of this section as if it had not been surrendered to the

relevant group member.

(5)   

Any amounts to be applied under subsection (2) or (3) in discharging

25

any liability of a company to pay corporation tax for an accounting

period are to be so applied before any amounts that may be so

applied under step 1, 4 or 5 in section 104N(2).

(6)   

The surrender by a company of the whole or any part of the step 2

amount to another company under this section—

30

(a)   

is not to be taken into account in determining the profits or

losses of either company for corporation tax purposes, and

(b)   

for corporation tax purposes is not to be regarded as the

making of a distribution.

(7)   

Any reference in this section to the set-off amount, or the net value of

35

the set-off amount, is to be read in accordance with section 104N.

104P    

Total expenditure on workers

(1)   

For the purposes of section 104N, the amount of a company’s total

expenditure on workers for an accounting period is the sum of—

(a)   

the relevant portion of the company’s staffing costs for the

40

period (see subsection (2)), and

(b)   

if the company is a member of a group and has incurred

expenditure on any externally provided workers, the

relevant portion of any staffing costs for the period incurred

by another member of the group (the “relevant group

45

company”) in providing any of those workers for the

company (see subsection (3)).

 
 

Finance Bill
Schedule 15 — R&D expenditure credits
Part 1 — Amendments of CTA 2009

258

 

(2)   

The relevant portion of the company’s staffing costs for an

accounting period is the amount of those costs that—

(a)   

are paid to, or in respect of, directors or employees who are

directly and actively engaged in relevant research and

development (whether they are wholly or partly so engaged),

5

and

(b)   

form part of the total amount of the company’s PAYE and

NIC liabilities for the accounting period (see section 104Q).

(3)   

The relevant portion of any staffing costs for an accounting period

incurred by a relevant group company in providing externally

10

provided workers for the company is the sum of the amounts to be

determined in the case of each of those workers as follows—

   

Step 1

   

Calculate the amount of expenditure that—

(a)   

has been incurred by the relevant group company in

15

providing the externally provided worker for the company,

(b)   

has been incurred on staffing costs, and

(c)   

forms part of the total amount of the relevant group

company’s PAYE and NIC liabilities for the accounting

period (see section 104Q).

20

   

Step 2

   

Calculate the percentage (the “appropriate percentage”) given by—equation: cross[over[char[R],char[T]],num[100.0000000000000000,"100"]]

   

where—

R is the amount of the company’s qualifying expenditure on the

externally provided worker that has been taken into account

25

in calculating the amount of the company’s qualifying R&D

expenditure for the period, and

T is the total amount of the company’s qualifying expenditure

on the externally provided worker.

   

Step 3

30

   

The amount to be determined in the case of the externally provided

worker is the appropriate percentage of the amount given by step 1.

104Q    

Total amount of company’s PAYE and NIC liabilities

(1)   

For the purposes of section 104P the total amount of a company’s

PAYE and NIC liabilities for an accounting period is the sum of—

35

(a)   

amount A, and

(b)   

amount B.

(2)   

Amount A is the total amount of income tax for which the company

is required to account to an officer of Revenue and Customs under

PAYE regulations for the accounting period.

40

(3)   

In calculating amount A disregard any deduction the company is

authorised to make in respect of child tax credit or working tax

credit.

 
 

Finance Bill
Schedule 15 — R&D expenditure credits
Part 1 — Amendments of CTA 2009

259

 

(4)   

Amount B is the total amount of Class 1 national insurance

contributions for which the company is required to account to an

officer of Revenue and Customs for the accounting period.

(5)   

In calculating amount B disregard any deduction the company is

authorised to make in respect of payments of statutory sick pay,

5

statutory maternity pay, child tax credit or working tax credit.

(6)   

In a case where the company is required to account for any amount

of income tax or Class 1 national insurance contributions for a

payment period that does not fall wholly within the accounting

period, the portion of that amount to be included in the total amount

10

of the company’s PAYE and NIC liabilities for the accounting period

is to be determined on such basis as is just and reasonable in all the

circumstances.

104R    

Surrender of credit to other group companies

(1)   

This section applies if—

15

(a)   

a company is entitled to an R&D expenditure credit under

this Chapter for an accounting period (“the surrender

period”), and

(b)   

the company surrenders the whole or any part of the credit to

another member of the group (the “relevant group member”)

20

under step 5 in section 104N(2).

(2)   

In this section an accounting period of a relevant group member is a

“relevant accounting period” if there is a period (“the overlapping

period”) that is common to the accounting period and the surrender

period.

25

(3)   

The amount surrendered is to be applied in discharging any liability

of the relevant group member to pay corporation tax for any relevant

accounting period as follows—

   

Step 1

   

Take the proportion of the relevant accounting period included in

30

the overlapping period.

   

Apply that proportion to the amount of corporation tax payable by

the relevant group member for the relevant accounting period.

   

Step 2

   

Take the proportion of the surrender period included in the

35

overlapping period.

   

Apply that proportion to the amount surrendered to the relevant

group member.

   

Step 3

   

The amount given by step 2 is to be applied in discharging the

40

amount given by step 1.

(4)   

If any of the amount surrendered is remaining after the operation of

step 3 in subsection (3), it is to be treated for the purposes of section

104N as if it had not been surrendered to the relevant group member.

(5)   

The surrender by a company of the whole or any part of an R&D

45

expenditure credit to another company under step 5 in section

104N(2)—

 
 

Finance Bill
Schedule 15 — R&D expenditure credits
Part 1 — Amendments of CTA 2009

260

 

(a)   

is not to be taken into account in determining the profits or

losses of either company for corporation tax purposes, and

(b)   

for corporation tax purposes is not to be regarded as the

making of a distribution.

104S    

Restrictions on payment of R&D expenditure credit

5

(1)   

This section applies if—

(a)   

a company is entitled to an R&D expenditure credit for an

accounting period under this Chapter, and

(b)   

an amount of the R&D expenditure credit is payable to the

company under step 7 of section 104N(2).

10

(2)   

If at the time of claiming the credit the company was not a going

concern (see section 104T)—

(a)   

the company is not entitled to be paid that amount, and

(b)   

that amount is extinguished.

(3)   

But if the company becomes a going concern on or before the last day

15

on which an amendment of the company’s tax return for the

accounting period could be made under paragraph 15 of Schedule 18

to FA 1998, the company is entitled to be paid that amount.

(4)   

If the company’s tax return for the accounting period is enquired into

by an officer of Revenue and Customs—

20

(a)   

no payment of that amount need be made before the officer’s

enquiries are completed (see paragraph 32 of Schedule 18 to

FA 1998), but

(b)   

the officer may make a payment on a provisional basis of

such amount as the officer thinks fit.

25

(5)   

No payment of that amount need be made if the company has

outstanding PAYE and NIC liabilities for the period.

(6)   

A company has outstanding PAYE and NIC liabilities for an

accounting period if it has not paid to an officer of Revenue and

Customs any amount that it is required to pay—

30

(a)   

under PAYE regulations, or

(b)   

in respect of Class 1 national insurance contributions,

   

for payment periods ending in the accounting period.

104T    

“Going concern”

(1)   

For the purposes of section 104S(2) and (3) a company is a going

35

concern if—

(a)   

its latest published accounts were prepared on a going

concern basis, and

(b)   

nothing in those accounts indicates that they were only

prepared on that basis because of an expectation that the

40

company would receive R&D expenditure credits under this

Chapter.

   

This is subject to subsection (2).

(2)   

A company is not a going concern at any time if it is in administration

or liquidation at that time.

45

(3)   

For the purposes of this section a company is in administration if—

 
 

Finance Bill
Schedule 15 — R&D expenditure credits
Part 1 — Amendments of CTA 2009

261

 

(a)   

it is in administration under Part 2 of the Insolvency Act 1986

or Part 3 of the Insolvency (Northern Ireland) Order 1989 (S.I.

1989/2405 (N.I. 19)), or

(b)   

a corresponding situation under the law of a country or

territory outside the United Kingdom exists in relation to the

5

company.

(4)   

For the purposes of this section a company is in liquidation if—

(a)   

it is in liquidation within the meaning of section 247 of that

Act or Article 6 of that Order, or

(b)   

a corresponding situation under the law of a country or

10

territory outside the United Kingdom exists in relation to the

company.

(5)   

Section 436(2) of the Companies Act 2006 (meaning of “publication”

of documents) has effect for the purposes of this section.

Insurance companies

15

104U    

Insurance companies treated as large companies

(1)   

This section applies if an insurance company—

(a)   

carries on life assurance business in an accounting period,

and

(b)   

is a small or medium-sized enterprise in the period.

20

(2)   

For the purposes of this Chapter the company is to be treated as if it

were not such an enterprise in the period (and accordingly is to be

treated as a large company for the purposes of this Chapter).

(3)   

Section 1119 (meaning of “small or medium-sized enterprise”), as it

has effect for the purposes of this Chapter (see section 104Y), is to be

25

read subject to this section.

104V    

Entitlement to credit: I minus E basis

(1)   

This section applies if—

(a)   

for an accounting period, an insurance company is charged to

tax in respect of its basic life assurance and general annuity

30

business in accordance with the I-E rules, and

(b)   

the calculation of the company’s charge to tax for the period

in respect of that business does not involve the calculation of

any BLAGAB trade profit or loss of the company.

(2)   

Section 104A has effect as if—

35

(a)   

the reference in subsection (1) to calculating the profits of a

trade were a reference to calculating the I-E profit of the basic

life assurance and general annuity business carried on by the

company, and

(b)   

the reference in subsection (2) to qualifying R&D expenditure

40

allowable as a deduction in calculating the profits of a trade

for an accounting period were a reference to any such

expenditure that would be allowable as such a deduction if

the company were to calculate its BLAGAB trade profit or

loss for the period.

45

 
 

Finance Bill
Schedule 15 — R&D expenditure credits
Part 1 — Amendments of CTA 2009

262

 

(3)   

Any receipt to be brought into account by virtue of this section is to

be treated for the purposes of section 92 of FA 2012 (certain BLAGAB

trading receipts to count as deemed I-E receipts) as if it had been

taken into account in calculating the company’s BLAGAB trade

profit or loss for the period.

5

(4)   

In this section “BLAGAB trade profit” and “BLAGAB trade loss”

have the meaning given by section 136 of FA 2012.

Group companies

104W    

R&D expenditure of group companies

(1)   

This section applies if—

10

(a)   

a company (“A”) incurs expenditure on making a payment to

another company (“B”) in respect of activities contracted out

by A to B,

(b)   

the activities would, if carried out by A, be research and

development of A (taken together with A’s other activities),

15

and

(c)   

A and B are members of the same group at the time the

payment is made.

(2)   

If the activities are undertaken by B itself, they are to be treated for

the purposes of this Chapter (so far as it would not otherwise be the

20

case) as research and development undertaken by B itself.

(3)   

If B makes a payment to a third party (“C”), any of the activities—

(a)   

contracted out by B to C, and

(b)   

undertaken by C itself,

   

are to be treated for the purposes of this Chapter (so far as it would

25

not otherwise be the case) as research and development contracted

out by B to C.

Anti-avoidance

104X    

Artificially inflated claims for credit

(1)   

To the extent that a transaction is attributable to arrangements

30

entered into wholly or mainly for a disqualifying purpose, it is to be

disregarded for the purpose of determining for an accounting period

R&D expenditure credits to which a company is entitled under this

Chapter.

(2)   

Arrangements are entered into wholly or mainly for a “disqualifying

35

purpose” if their main object, or one of their main objects, is to enable

a company to obtain—

(a)   

an R&D expenditure credit under this Chapter to which it

would not otherwise be entitled, or

(b)   

an R&D expenditure credit under this Chapter of a greater

40

amount than that to which it would otherwise be entitled.

(3)   

In this section “arrangements” includes any scheme, agreement or

understanding, whether or not legally enforceable.

 
 

 
previous section contents continue
 
House of Lords home page Houses of Parliament home page House of Commons home page search page enquiries

© Parliamentary copyright 2013
Revised 4 July 2013